Paraoxonase-1 activity determination via paraoxon substrate yields no significant difference in mild hyperhomocysteinemia

International Journal of Cardiology

Volumn 145, Issue 1, 2010, Pages 42-43

  Türkeli, Hatice ^a   Çayci, Tuncer ^a   Akgül, Emin Özgür ^a   MacIt, Enis ^a   Yaman, Halil ^a   Aydin, Ibrahim ^a   Demirin, Hilmi ^a   Alacam, Hasan ^b   Özkan, Esin ^a   Çakir, Erdinç ^a   Deren, Özgür ^b   Erbil, Mehmet Kemal ^a   Kunak, Z Ilker ^a   Burat, Kutlay ^a   Akman, Şerif ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Homocysteine; Hyperhomocysteinemia; Paraoxonase

Indexed keywords

ALBUMIN; ARYLDIALKYLPHOSPHATASE 1; FERRITIN; FIBRINOGEN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; LOW DENSITY LIPOPROTEIN; METHIONINE; PARAOXON;

ARTERY DISEASE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME SUBSTRATE; ETHICS; FEEDING BEHAVIOR; HUMAN; HYDROLYSIS; HYPERHOMOCYSTEINEMIA; LETTER; LIQUID CHROMATOGRAPHY; MEDICAL LITERATURE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SPECTROPHOTOMETRY; VEIN THROMBOSIS;

EID: 78049475075     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.138     Document Type: Article

References (12)

1. N. Janel, K. Robert, C. Chabert, A. Ledru, C. Gouédard, R. Barouki, J.M. Delabar, and J.F. Chassé Mouse liver paraoxonase-1 gene expression is downregulated in hyperhomocysteinemia Thromb Haemost 92 2004 221 222
2. S.S. Kang, P.W. Wong, and M.R. Malinow Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease Annu Rev Nutr 12 1992 279 298
3. M. Den Heijer, T. Koster, H.J. Blom, G.M. Bos, E. Briet, P.H. Reitsma, J.P. Vandenbroucke, and F.R. Rosendaal Hyperhomocysteinemia as a risk factor for deep-vein thrombosis N Engl J Med 334 1996 759 762
4. H. JakubowskI Calcium-dependent human serum homocysteine thiolactone hydrolase-a protective mechanism against protein N-homocysteinylation J Biol Chem 275 6 2000 3957 3962
5. L.J. Langman, and D.E.C. Cole Cholesterol of the 90's? Clin Chim 286 1999 63 80
6. J. Perla-Kajan, T. Twardowski, and H. Jakubowski Mechanisms of homocysteine toxicity in humans Amino Acids 32 2007 561 572
7. H.W. Eckerson, C.M. Wyte, D.U. LA, and BN The human serum paraoxonase/arylesterase polymorphism Am J Hum Genet 35 6 1983 1126 1138
8. M. Kerkeni, F. Addad, M. Chauffert, L. Chuniaud, A. Miled, F. Trivin, and K. Maaroufi Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease Clinical Biochemistry 39 2006 821 825
9. A. Aharoni, L. Gaidukov, S. Yagur, L. Toker, I. Silman, and D.S. Tawfik Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization PNAS 101 2 Jan 13 2004 482 487
10. R. Zech, R.M. Severin, J.M. Chemnitius, and K. Nebendahl Paraoxonase polymorphism in rabbits Chemico-Biological Interactions 119-120 1999 283 288
11. Costa LG, Furlong CE. Paraoxonase (PON1) in health and disease: Basic and Clinical Aspects. Kluwer Academic Publishers.
12. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150